These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10551408)

  • 1. p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases.
    Marrogi AJ; Khan MA; Vonderheid EC; Wood GS; McBurney E
    J Cutan Pathol; 1999 Sep; 26(8):369-78. PubMed ID: 10551408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression.
    Li G; Chooback L; Wolfe JT; Rook AH; Felix CA; Lessin SR; Salhany KE
    J Invest Dermatol; 1998 May; 110(5):767-70. PubMed ID: 9579543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of cutaneous B- and T-cell lymphomas.
    Neri A; Fracchiolla NS; Roscetti E; Garatti S; Trecca D; Boletini A; Perletti L; Baldini L; Maiolo AT; Berti E
    Blood; 1995 Oct; 86(8):3160-72. PubMed ID: 7579411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
    Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
    Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical cutaneous lymphocytic infiltrate and a role for quantitative immunohistochemistry and gene rearrangement studies.
    Fucich LF; Freeman SF; Boh EE; McBurney E; Marrogi AJ
    Int J Dermatol; 1999 Oct; 38(10):749-56. PubMed ID: 10561046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 alterations in porokeratosis.
    Arranz-Salas I; Sanz-Trelles A; Ojeda DB
    J Cutan Pathol; 2003 Aug; 30(7):455-8. PubMed ID: 12859744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 gene mutations in squamous cell carcinoma occurring in scars: comparison with p53 protein immunoreactivity.
    Sakatani S; Kusakabe H; Kiyokane K; Suzuki K
    Am J Dermatopathol; 1998 Oct; 20(5):463-7. PubMed ID: 9790106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor.
    Wolfe JT; Chooback L; Finn DT; Jaworsky C; Rook AH; Lessin SR
    J Clin Oncol; 1995 Jul; 13(7):1751-7. PubMed ID: 7602365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma.
    Li JJ; Huang YQ; Cockerell CJ; Zhang WG; Nicolaides A; Friedman-Kien AE
    Am J Dermatopathol; 1997 Aug; 19(4):373-8. PubMed ID: 9261472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma.
    Ninomiya Y; Urano Y; Yoshimoto K; Iwahana H; Sasaki S; Arase S; Itakura M
    J Dermatol Sci; 1997 Mar; 14(3):173-8. PubMed ID: 9138474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.
    Matsushima AY; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1994 Mar; 144(3):573-84. PubMed ID: 8129043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis.
    Kubo Y; Urano Y; Yoshimoto K; Iwahana H; Fukuhara K; Arase S; Itakura M
    J Invest Dermatol; 1994 Apr; 102(4):440-4. PubMed ID: 8151121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients.
    Lam KY; Tsao SW; Zhang D; Law S; He D; Ma L; Wong J
    Int J Cancer; 1997 Apr; 74(2):212-9. PubMed ID: 9133458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic and immunophenotypic features prior to transformation in patients with transformed cutaneous T-cell lymphoma: is CD25 expression in skin biopsy samples predictive of large cell transformation in cutaneous T-cell lymphoma?
    Stefanato CM; Tallini G; Crotty PL
    Am J Dermatopathol; 1998 Feb; 20(1):1-6. PubMed ID: 9504661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
    Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
    Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
    Günther T; Schneider-Stock R; Rys J; Niezabitowski A; Roessner A
    J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.